RSH is tackling a critical issue in the U.S. healthcare system: the staggering 15% of insurance claims that are denied annually, costing providers an estimated $262 billion in lost revenue. RSH's flagship technology, Daniel, leverages machine learning to analyze historical claims data, identify errors, and streamline resubmission processes, enabling providers to recover lost revenue with unprecedented efficiency.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 01/13/25 | $3,000,000 | Seed |
Gleb Drobkov Mike Dezube Trevor Burgess | undisclosed |
